Global Rheumatoid Arthritis Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 26-Jan-2023
No. of pages: 121

Arthritis is a vast term, which includes an umbrella of 100 different types of arthritis, the most common ones being osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), fibromyalgia and gout. Rheumatoid arthritis is an autoimmune disorder in which the immune system of the patient's body forms antibodies against synovial tissue—a specialized connective tissue. Loss of tissue lining causes friction in the bones and they tend to deform, which is called rheumatoid arthritis.

The report focuses on the Rheumatoid Arthritis Treatment market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Rheumatoid Arthritis Treatment market.

Major Players in the Rheumatoid Arthritis Treatment market are:

UCB S.A.

AbbVie Inc.

Eli Lilly & Company

Johnson & Johnson

Sanofi SA

Sobi Inc.

Amgen Inc.

F. Hoffman-La Roche AG

Bristol-Myers Squibb Company

Pfizer Inc.

On the basis of types, the Rheumatoid Arthritis Treatment market is primarily split into:

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Disease-modifying anti-rheumatic drugs (DMARDs)

On the basis of applications, the market covers:

Hospital

Retail Pharmacies

Drugstores

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Rheumatoid Arthritis Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Rheumatoid Arthritis Treatment Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis Treatment Market
1.2 Rheumatoid Arthritis Treatment Market Segment by Type
1.2.1 Global Rheumatoid Arthritis Treatment Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Rheumatoid Arthritis Treatment Market Segment by Application
1.3.1 Rheumatoid Arthritis Treatment Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Rheumatoid Arthritis Treatment Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Rheumatoid Arthritis Treatment (2017-2029)
1.5.1 Global Rheumatoid Arthritis Treatment Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Rheumatoid Arthritis Treatment Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Rheumatoid Arthritis Treatment Industry
1.7 Impact of Carbon Neutrality on the Rheumatoid Arthritis Treatment Industry

2 Rheumatoid Arthritis Treatment Market Upstream and Downstream Analysis
2.1 Rheumatoid Arthritis Treatment Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Rheumatoid Arthritis Treatment Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 UCB S.A.
3.1.1 UCB S.A. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.1.4 Business Overview
3.2 AbbVie Inc.
3.2.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Eli Lilly & Company
3.3.1 Eli Lilly & Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Johnson & Johnson
3.4.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Sanofi SA
3.5.1 Sanofi SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Sobi Inc.
3.6.1 Sobi Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Amgen Inc.
3.7.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.7.4 Business Overview
3.8 F. Hoffman-La Roche AG
3.8.1 F. Hoffman-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Bristol-Myers Squibb Company
3.9.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Pfizer Inc.
3.10.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Rheumatoid Arthritis Treatment Market Performance (2017-2022)
3.10.4 Business Overview

4 Global Rheumatoid Arthritis Treatment Market Landscape by Player
4.1 Global Rheumatoid Arthritis Treatment Sales and Share by Player (2017-2022)
4.2 Global Rheumatoid Arthritis Treatment Revenue and Market Share by Player (2017-2022)
4.3 Global Rheumatoid Arthritis Treatment Average Price by Player (2017-2022)
4.4 Global Rheumatoid Arthritis Treatment Gross Margin by Player (2017-2022)
4.5 Rheumatoid Arthritis Treatment Market Competitive Situation and Trends
4.5.1 Rheumatoid Arthritis Treatment Market Concentration Rate
4.5.2 Rheumatoid Arthritis Treatment Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Rheumatoid Arthritis Treatment Sales, Revenue, Price Trend by Type
5.1 Global Rheumatoid Arthritis Treatment Sales and Market Share by Type (2017-2022)
5.2 Global Rheumatoid Arthritis Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Rheumatoid Arthritis Treatment Price by Type (2017-2022)
5.4 Global Rheumatoid Arthritis Treatment Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Rheumatoid Arthritis Treatment Sales, Revenue and Growth Rate of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) (2017-2022)
5.4.2 Global Rheumatoid Arthritis Treatment Sales, Revenue and Growth Rate of Corticosteroids (2017-2022)
5.4.3 Global Rheumatoid Arthritis Treatment Sales, Revenue and Growth Rate of Disease-modifying anti-rheumatic drugs (DMARDs) (2017-2022)

6 Global Rheumatoid Arthritis Treatment Market Analysis by Application
6.1 Global Rheumatoid Arthritis Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Rheumatoid Arthritis Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Rheumatoid Arthritis Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Rheumatoid Arthritis Treatment Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Rheumatoid Arthritis Treatment Consumption and Growth Rate of Retail Pharmacies (2017-2022)
6.3.3 Global Rheumatoid Arthritis Treatment Consumption and Growth Rate of Drugstores (2017-2022)

7 Global Rheumatoid Arthritis Treatment Sales and Revenue Region Wise (2017-2022)
7.1 Global Rheumatoid Arthritis Treatment Sales and Market Share, Region Wise (2017-2022)
7.2 Global Rheumatoid Arthritis Treatment Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Rheumatoid Arthritis Treatment Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Rheumatoid Arthritis Treatment Market Forecast (2022-2029)
8.1 Global Rheumatoid Arthritis Treatment Sales, Revenue Forecast (2022-2029)
8.1.1 Global Rheumatoid Arthritis Treatment Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Rheumatoid Arthritis Treatment Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Rheumatoid Arthritis Treatment Price and Trend Forecast (2022-2029)
8.2 Global Rheumatoid Arthritis Treatment Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.3 China Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.5 India Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Rheumatoid Arthritis Treatment Sales and Revenue Forecast (2022-2029)
8.3 Global Rheumatoid Arthritis Treatment Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Rheumatoid Arthritis Treatment Revenue and Growth Rate of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) (2022-2029)
8.3.2 Global Rheumatoid Arthritis Treatment Revenue and Growth Rate of Corticosteroids (2022-2029)
8.3.3 Global Rheumatoid Arthritis Treatment Revenue and Growth Rate of Disease-modifying anti-rheumatic drugs (DMARDs) (2022-2029)
8.4 Global Rheumatoid Arthritis Treatment Consumption Forecast by Application (2022-2029)
8.4.1 Global Rheumatoid Arthritis Treatment Consumption Value and Growth Rate of Hospital (2022-2029)
8.4.2 Global Rheumatoid Arthritis Treatment Consumption Value and Growth Rate of Retail Pharmacies (2022-2029)
8.4.3 Global Rheumatoid Arthritis Treatment Consumption Value and Growth Rate of Drugstores (2022-2029)
8.5 Rheumatoid Arthritis Treatment Market Forecast Under COVID-19

9 Industry Outlook
9.1 Rheumatoid Arthritis Treatment Market Drivers Analysis
9.2 Rheumatoid Arthritis Treatment Market Restraints and Challenges
9.3 Rheumatoid Arthritis Treatment Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Rheumatoid Arthritis Treatment Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Rheumatoid Arthritis Treatment Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Rheumatoid Arthritis Treatment Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
  • Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
  • Global Bio-pharma Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......
  • Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
    Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273
    “Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
  • Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • 2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85
    This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......
  • Global Bio-pharma Market Insights, Forecast to 2029
    Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108
    The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
  • Biopharmaceuticals Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233
    China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs